THE IN OVO CARCINOGENEICITY ASSAY (IOCA): A REVIEW OF AN EXPERIMENTAL APPROACH FOR RESEARCH ON CARCINOGENESIS AND CARCINOGENICITY TESTING

Harald Enzmann¹ and Klaus D. Brunnemann²

1Bayer AG, Institute of Toxicology, 42096 Wuppertal, Germany and ²American Health Foundation, Valhalla, NY 10595, USA

Received 7/21/97 Accepted 11/14/97

8. REFERENCES

1. K. Yamagiwa & K. Ichikawa: Experimentelle Studie über die Pathogenese der Epithelialgeschwülste. Mitteilungen Med Fakultät Kaiserl Univ Tokyo 15, 295-344 (1915)

2. P. Rous: A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13, 397-411 (1911)

3. M.C. Lancaster, F.P. Jenkins, J. Philip: Toxicity associated with certain samples of groundnuts. Nature 192, 1095-1096 (1961)

4. L. Cova, A. Duflot, M. Prave & C. Trepo: Duck hepatitis B virus infection aflatoxin B1 and liver cancer in ducks. [Review] Arch of Virology - Supplementum 8, 81-7 (1993)

5. A.E. al Moustafa, B. Quatannens, F. Dieterlen-Lievre & S. Saule: Tumorigenic effects mediated in the avian embryo by one or more oncogenes associated with v-myc. Oncogene 7, 1667-70 (1992)

6. KH. Tempel, A. Ignatius & I. Stammberger: A short-term test for nucleotoxicity that uses chick embryo cells treated in vitro and in vivo - physico-chemical and biochemical investigations. Comp Biochem Physiol 103C, 73-78 (1992)

7. C.R. Short, W. Flory, L.C. Hsieh, T. Aranas, S.P. Ou & J. Weissinger : Comparison of hepatic drug metabolizing enzyme activities in several agricultural species. Comp Biochem Physiol 91, 419-422 (1988)

8. B. Brunström: Activities in chick embryos of 7-ethoxycoumarin O-deethylase and acryl hydrocarbon (benzo[a]pyrene) hydrolase and their induction by 3,3',4,4'- tetrachlorobiphenyl in early embryos. Xenobiotics 16, 865-872 (1986)

9. JW. Hamilton & S.E. Bloom: Correlation between mixed-function oxidase enzyme induction and aflatoxin B1-induced unscheduled DNA synthesis in the chick embryo in vivo. Environ Mutagenesis 6, 41-48 (1984)

10. H. Enzmann, G. Kaliner, B. Watta-Gebert & E. Löser: Foci of altered hepatocytes induced in embryonal turkey liver. Carcinogenesis 13, 943-946 (1992)

11. H. Enzmann, C. Kühlem, G. Kaliner, E. Löser & P. Bannasch: Rapid induction of preneoplastic liver foci in embryonal turkey liver by diethylnitrosamine. Toxicol Pathol 23, 60-569 (1995)

12. P.Bannasch : The cytoplasm of hepatocytes during carcinogenesis. Electron and light microscopical investigations of the nitrosomorpholine-intoxicated rat liver. Rec Res Cancer Res 19, 1-100 (1968)

13. Y. Ruan, H.J. Hacker, H. Zerban & P. Bannasch: Ultrastructural and immunocytochemical characterization of the cellular phenotype in primary adenoid liver tumours of the rat. Path Res Pract 184, 223-233 (1989)

14. S.N Thung,: The development of proliferating ductular structures in liver disease. Arch Pathol Lab Med 114, 407-411 (1990)

15. A.M. Vandersteenhoven, J Burchette & G Michalopoulos: Characterization of ductular hepatocytes in end-stage cirrhosis. Arch Pathol Lab Med 114, 403-406 (1990)

16. P. Gerlyng, T.Stokke, H.S: Huitfeldt, T. Stenersen, H.E. Danielsen, T. Grotmol & P.O. Seglen: Analytical methods for the study of liver cell proliferation. Cytometry 13, 404 - 415 (1992)

17. A.M. Rappaport: Physioanatomical basis of toxic liver in jury. In: Toxic injury of the liver. Eds: E. Farber & M.M. Fischer, Marcel Dekker, New York, USA, 1-55 (1979)

18. J.J. Gumucio & D.L. Miller: Functional implications of liver cell heterogeneity. Gasteroenterology 80, 393-403 (1981)

19. J. James, J. Tas. K.S. Bosch. A.J.P. de Meere & H.C. Schuyt: Growth patterns of rat hepatocytes during postnatal development. Eur J Cell Biol 19, 222-226 (1979)

20. H.W. Kunz, H.A. Tennekes, R.E. Port, M. Schwartz, D. Lorke,& G. Schaude: Quantitative aspects of chemical carcinogenesis and tumor promotion in liver. Environ Health Perspect 50, 113-122 (1983)

21. J. Carlson & R. Abraham: Nuclear ploidy of neonatal rat livers: Effects of two hepatic carcinogens (mirex and dimethylnitrosamine) J Toxicol Environ Health 15, 551-559 (1985)

22. A.J. Ingram & P.Grasso: Nuclear Enlargement - An early change produced in mouse epidermis by carcinogenic chemicals applied topically in the presence of a promoter. J Appl Toxicol 5, 53-60 (1985)

23. A.J. Ingram & P. Grasso: Nuclear enlargement produced in mouse skin by carcinogenic mineral oils. J Appl Toxicol 7, 289-295 (1987)

24. H. Enzmann, & P. Bannasch: Morphometric study of alterations of extrafocal hepatocytes of rat liver treated with N-nitrosomorpholine. Virchows Archiv B, 53, 218-226 (1987)

25. J.A. Styles, M. Kelly & C.R. Elcombe: A cytological comparison between regeneration, hyperplasia and early neoplasia in the rat liver. Carcinogenesis 8, 391-399 (1987)

26. J.A. Styles, A. Bybee,N.R. Pritchard & M.D. Kelly: Studies on the hyperplastic responsiveness of binucleated rat hepatocytes. Carcinogenesis 11, 1149-1152 (1990)

27. P. Gerlyng, T. Grotmol, T. Stokke, B. Erikstein& P.O. Seglen: Flow cytometric investigation of a possible precursor-product relationship between oval cells and parenchymal cells in the rat liver. Carcinogenesis 15, 53-59 (1994)

28. R.A. Finch, I.M.Evans, & H.B. Bosmann: Chemical carcinogen in vitro testing: A method for sizing cell nuclei in the nuclear enlargement assay. Toxicology 15, 145-154(1980)

29. P. Gerlyng,, A. Abyholm,T. Grotmol, B. Erikstein, H.S. Huitfeldt, T. Stokke & P.O. Seglen: Binucleation and polyploidization patterns in developmental regenerative rat liver growth. Cell Proli 26, 557-565 (1993)

30. J. James, M. Schopman & P. Delfgaauw: The nuclear pattern or the parenchymal cells of the liver after partial hepatectomy. Exp Cell Res., 42, 375-379 (1966)

31. C. Melchiorri, P. Chieco, A.I: Zedda, P. Coni, G.M. Ledda-Columbano & A. Columbano: Ploidy and nuclearity of rat hepatocytes after compensatory regeneration or mitogen-induced liver growth. Carcinogenesis 14, 1825-1830 (1993)

32. O. Klinge: Cytologic and histologic aspects of toxicologically induced liver reactions. Cur Top Pathol 85, 91-116 (1973)

33. H.S. Taper & P. Bannasch: Histochemical differences between so-called megalocytosis and neoplastic or preneoplastic liver lesions induced by N-nitrosomorpholine. Eur J Cancer 15, 189-196 (1979)

34. G.A. Clawson, L.J. Blankenship, J.G. Rhame, & D.S. Wilkinson: Nuclear enlargement induced by hepatocarcinogens alters ploidy. Cancer Res 52, 1304-1308 (1992)

35. Y. Fujimoto, M. Oyamada, A. Hattori, H. Takahashi, M. Sawaki, K. Dempo,M. Mori, & M. Nagao: Accumulation of abnormally high ploid nuclei in the liver of LEC rats developing spontaneous hepatitis. Jpn J Cancer Res 80, 45-50 (1989)

36. M. Sawaki, K. Enomoto, H. Takahashi, Y. Nakajima & M. Mori: Phenotype of preneoplastic and neoplastic liver lesions during spontaneous liver carcinogenesis of LEC rats. Carcinogenesis 11, 1857-1861 (1990)

37. H. Enzmann, C. Kühlem, E. Löser & P. Bannasch: Dose dependence of diethylnitrosamine-induced nuclear enlargment in embryonal turkey liver. Carcinogenesis 16, 1351-1355 (1995)

38. A. Oenfelt: Spindle disturbances in mammalian cells. III. Toxicity, c-mitoses and aneuploidy with 22 different compounds. Specific and unspecific mechanisms. Mutat Res 182, 135-154 (1987)

39. L. Wiest: The effect of diethylnitrosamine on the distribution of cell classes in the parenchyma of the liver of newborn rats. Eur J Cancer 8, 121-125 (1972)

40. G.M. Williams: Phenotypic properties of preneoplastic rat liver lesions and applications to detection of carcinogens and tumor promoters. Toxicol. Pathol. 10, 3-10 (1982)

41. P. Bannasch: Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 7, 689-695(1986)

42. N. Ito, K. Imaida, R. Hasegawa & H. Tsuda: Rapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis CRC. Crit Rev Toxicol 19, 386-415 (1989)

43. T. Sasaki & T. Yoshida: Experimentelle Erzeugung des Lebercarcinoms durch Fütterung mit o-Amidoazotoluol. Virchows Arch Path Anat 295. 175-200 (1935)

44. P. Bannasch,H. Enzmann, F. Klimek, E. Weber & H. Zerban: Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis. Toxicol Pathol 17, 617-629 (1989)

45. H. Enzmann, H. Zerban, E. Löser & P. Bannasch: Glycogen phosphorylase hyperactive foci of altered hepatocytes in aged rats. Virchows Arch B 62, 3-8 (1992)

46. H. Enzmann & P. Bannasch: Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis 8, 1607-1612 (1987)

47. M.A. Moore, D. Mayer, & P. Bannasch: The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis 3, 1429-1436 (1982)

48. E. Weber & P. Bannasch: Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia induced by single oral exposures to N-nitrosomorpholine. Carcinogenesis 15, 1219-1226 (1994a)

49. E. Weber & P. Bannasch: Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine. Carcinogenesis 15, 1227-1234 (1994b)

50. E. Weber & P. Bannasch: Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia induced by continuous oral exposures to N-nitrosomorpholine. Carcinogenesis 15, 1235-1242 (1994c)

51. P. Bannasch, U. Benner, H. Enzmann & H.J. Hacker: Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1. Carcinogenesis 6, 1641-1648 (1985)

52. H. Enzmann, P. Bannasch: Non-persisting early foci of altered hepatocytes induced in rats by N-nitrosomorpholine. J Cancer Res Clin Oncol 114, 30-34 (1988)

53. E. Weber, MA. Moore, P. Bannasch: Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandosteron and N-nitrosomorpholine. Carcinogenesis 9, 1049-1054 (1988)

54. H. Enzmann, D. Ohlhauser, T. Dettler, U. Benner, H.J. Hacker & P. Bannasch: Unusual histochemical pattern in preneoplastic hepatic foci characterized by hyperactivity of several enzymes. Virchows Arch B 57, 99-108 (1989)

55. A. Buchmann,W. Kuhlmann, M. Schwarz, W. Kunz, C.R. Wolf, E. Moll, T. Friedberg, & F. Oesch: Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis 6, 513-521 (1985)

56. H.J. Hacker, M.A. Moore, D. Mayer & P.Bannasch: Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis 3, 1265-1272(1982)

57. H. Zerban, S. Radig, A. Kopp-Schneider & P. Bannasch: Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotype cellular diversity and instability. Carcinogenesis 15, 2467-2473 (1994)

58. D. Mayer & B. Schäfer: Biochemical and morphological characterization of glycogen-storing epithelial liver cell lines. Exp Cell Res 138, 1-14 (1982)

59. C. Peraino, E.F. Staffeldt, B.A. Carnes, V.A. Ludeman, J.A. Blomquist & S.D. Vesselinovitch: Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res 44, 3340-3347 (1984)

60. G.G. Hatch, F.W. Edens, L.C. Rogers & B. Most: Embryotoxic, tumor, and other post-hatch effects of chemical carcinogens and noncarcinogens following in ovo yolk sac inoculation of Japanies quail. In: Evaluation of Short-term Tests for Carcinogens. Eds: Ashby, J., de Serres, F.J., Shelby, M.D., Margolin, B.H., Ishidate, M. and Becking, G.C., Cambridge University Press, Cambridge, UK, 2.35-2.42 (1988)

61. G.M. Williams & K. Watanabe: Quantitative kinetics of development of N-2-flourenylacetamide-induced altered hyperplastic hepatocellular foci resistant to iron accumulation and their reversion or persistence following removal of carcinogen. J Natl Cancer Inst 61, 113-121 (1978)

62. M.A. Moore, H.J. Hacker & P. Bannasch: Phenotypic instability in focal and nodular lesions induced in a short-term system in the rat liver. Carcinogenesis 4, 595-603 (1983)

63. M. Tatematsu, Y. Nagamine & E. Farber: Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res 43, 5049-5058 (1983)

64. R. Schulte-Hermann, W. Bursch, B. Krauppgrasl, F. Oberhammer, A. Wagner & R. Jirtle: Cell-proliferation and Apoptosis in normal liver and preneoplastic foci. Environ Health Perspect 101, 87-90 (1993)

65. B. Grasl-Kraupp, B. Ruttkay-Nedecky, L. Mullauer, H. Taper, W. Huber, W. Bursch & R. Schulte-Hermann: Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression. Hepatology 25, 906-912 (1997)

66. G. Seelmann-Eggebert, D. Mayer, D. Mecke & P. Bannasch: Expression and regulation of glycogen phosphorylase in preneoplastic and neoplastic hepatic lesions in rats. Virchows Arch B 53, 44-51(1987)

67. H.J. Hacker, P. Steinberg, I. Toshkov, F. Oesch & P. Bannasch: Persistence of the cholangiocellular and hepatocellular lesions observed in rats fed a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis 13, 271-276 (1992)

68. H. Enzmann, H. Zerban, A. Kopp-Schneider, E. Löser & P. Bannasch: Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogesis. Carcinogenesis 16, 1513-1518 (1995)

69. H.C. Pitot, T.L. Goldsworthy, S. Moran, W. Kennan, H.P. Glauert, R.R: Maronpot & H.A. Campbell: A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationship to altered hepatic foci. Carcinogenesis 8, 1491-1499 (1987)

70. M.A. Pereira & S.L. Herren-Freund: Liver initiation assay: the rat liver foci bioassay of carcinogens and noncarcinogens. In: Evaluation of short-term tests for carcinogens. Eds: J. Ashby, de Serres F.J., Shelby M.D., Margolin B.H., Ishidate M., Becking G.C., Cambridge University Press, Cambridge, UK, 1.325-1.328 (1988)

71. R.R. Maronpot, H.C., Pitot & C. Peraino: Use of rat liver altered focus models for testing chemicals that have completed two-year carcinogenicity studies. Toxicol Pathol 17, 651-662 (1989)

72. D. Oesterle, U. Gerbracht, E. Deml, B. Schlatterer & E. Eigenbrodt: Comparison of three rat liver foci bioassays-incidence of preneoplastic foci initiated by diethylnitrosamine. Carcinogenesis 10, 1891-1895 (1989)

73. P. Bannasch & H. Zerban:. Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response. In: Mechanisms of carcinogenesis in risk identification. Eds: Vainio, H., Magee, P.N., McGregor, D.B., and McMichel, A.J., IARC, Lyon, France, 389-427 (1992)

74. G.M. Williams: Chemicals with carcinogenic activity in the rodent liver; mechanistic evaluation of human risk. Cancer Letters 117, 175-188 (1997)

75. N. Ito, H. Tsuda, M. Tatematsu, T. Inoue, Y. Tagawa, T. Aoki, S. Uwagawa, M. Kagawa, T. Ogiso, T. Masui, K. Imaida, S. Fukushima & M. Asamoto: Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinogenesis 9, 387-394 (1988)

76. J.A. Allen & M.M. Coombs: Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature 287, 244-245 (1980)

77. L.G. Baggetto: Role of mitochondria in carcinogenesis. Eur J Cancer 29A, 156-159 (1993)

78. D.A. Clayton: Replication of animal mitochondrial DNA. Cell 28, 638-705 (1982)

79. G. Singh & E. Maniccia-Bozzo: Evidence for lack of mitochondrial DNA repair following cis-dichlorodiammineplatinum treatment. Cancer Chemother Pharmacol 26, 97-100 (1990)

80. D.D. Chang, R.P.Fisher & D.A. Clayton: Roles for a promotor and RNA processing in the synthesis of mitochondrial displacement-loop strands. Biochim and Biophys Acta 909, 85-91 (1987)

81. G. Singh, S.M. Sharkey & R. Moorehead: Mitochondrial DNA damage by anticancer agents. Pharmac Ther 54, 217-230 (1992)

82. B. Bandy & AJ Davison: Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging? Free Radic Biol Med 8, 523-539 (1990)

83. D.C. Wallace: Mitochondrial DNA in aging and disease. Scientific American 277 (1997)

84. G. Singh, W.W. Hauswirth, W.E. Ross & A:H. Neims: A method for assessing damage to mitochondrial DNA caused by radiation and epichlorohydrin. Mol Pharmacol 27, 167-170 (1985)

85. C. Welter, D. Dooley & N. Blin: A rapid protocol for the purification of mitochondrial DNA suitable for studying restriction fragment length polymorphisms. Gene 83, 169-172 (1989)

86. H. Enzmann, C. Kühlem, E. Löser & P. Bannasch: Damage to mitrochondrial DNA induced by the hepatocarcinogen diethylnitrosamine in ovo. Mutation Res 329, 113-120 (1995)

87. A. Martelli, L. Robbiano, G.M. Gazzaniga & G. Brambilla: Comparative study of DNA damage and repair induced by ten N-nitroso compounds in primary cultures of human and rat hepatocytes. Cancer Res 48, 4144-4152 (1988)

88. M. Zielenska & J.B. Guttenplan: Effects of UV repair, error-prone repair and critical site of mutation on mutagenesis induced by N-Nitrosamines. Mutation Res 180, 11-20 (1987)